Locally advanced rectal cancer: What is the evidence for induction chemoradiation?

Oncologist

Volumn 12, Issue 11, 2007, Pages 1309-1318

  Glynne Jones, Rob ^a,b   Harrison, Mark ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Chemoradiation; Circumferential resection margin; Neoadjuvant; Pathological complete response; Rectal cancer; Sphincter sparing surgery

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; REVIEW; SEPSIS; TREATMENT RESPONSE; WOUND HEALING IMPAIRMENT;

CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HUMANS; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; RECTUM; TREATMENT OUTCOME; WOUND HEALING;

EID: 36849055830     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.12-11-1309     Document Type: Review

References (52)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
2. Sauer R, Becker H, Hohenberger W et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
3. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004;72:15-24.
4. Gerard JP, Conroy T, Bonnetain F et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006;24:4620-4625.
5. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123.
6. Camma C, Giunta M, Fiorica F et al. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000;284:1008-1015.
7. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-1304.
8. Munro AJ, Bentley AHM. Adjuvant radiotherapy in operable rectal cancer: A systematic review. Semin Colon Rectal Surg 2002;13:31-42.
9. Wong RK, Tandan V, De Silva S et al. Preoperative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007;(2):CD002102.
10. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 1996;348:1605-1610.
11. Frykholm GJ, Pahlman L, Glimelius B. Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 2001;50:433-440.
12. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 2007;243:132-139.
13. Bosset JF, Pavy JJ, Hamers HP et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies. EORTC Radiotherapy Group. Eur J Cancer 1993;29A:1406-1410.
14. Minsky BD, Cohen AM, Kemeny N et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
15. Rich TA, Skibber JM, Ajani JA et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995; 32:1025-1029.
16. Crane CH, Skibber JM, Birnbaum EH et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumour response, leading to increased sphincter preservation in locally advanced low rectal cancer. Int J Radiat Oncol Biol Phys 2003;57:84-89.
17. Berrocal MG, de la Torre A, Arias F et al. Randomized phase III trial in locally advanced rectal cancer: Preoperative chemoradiotherapy with oral uracil and tegafur/leucovorin versus intravenous fluorouracil/leucovorin. Eur J Cancer 2005;3/2 (suppl):172.
18. Kim JS, Kim JS, Cho MJ et al. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. J Korean Med Sci 2006;21:52-57.
19. Glynne-Jones R, Dunst J, Sebag-Montefiore D. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: How successful have we been? Ann Oncol 2006;17:361-371.
20. Bosset JF, Calais G, Mineur L et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results-EORTC 22921. J Clin Oncol 2005;23:5620-5627.
21. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-1223.
22. Andre T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;23: 2343-2351.
23. Voelter V, Zouhair A, Vuilleumier H et al. CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: Results from a phase II. Br J Cancer 2006;95:710-716.
24. Krishnan S, Janjan NA, Skibber JM et al. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2006;66:762-771.
25. Emami B, Pilepich M, Willett C et al. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys 1982; 8:1295-1299.
26. Cohen AM, Minsky BD. Aggressive surgical management of locally advanced primary and recurrent rectal cancer. Current status and future directions. Dis Colon Rectum 1990;33:432-438.
27. Moertel CG, Childs DS Jr, Reitemeier RJ et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-867.
28. Rominger CJ, Gunderson LL, Gelber RD et al. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16). Am J Clin Oncol 1985;8:118-127.
29. Overgaard M, Bertelsen K, Dalmark M et al. A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma Acta Oncol 1993;32:547-553.
30. Braendengen M, Tveit KM, Berglund A et al. A randomised phase III study (LARCS) comparing preoperative radiotherapy alone with chemoradiotherapy in non-resectable rectal cancer. Eur J Cancer 2005;3/2(suppl 3):172.
31. Grann A, Feng C, Wong D et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987-995.
32. Rullier E, Goffre B, Bonell C. Preoperative radio-chemotherapy and sphincter saving resection in T3 carcinomas of the lower third of the rectum. Am Surg 2001;234:633-640.
33. Ruo L, Tikoo S, Klimstra D. Long term prognostic significance of extended rectal cancer response to preoperative radiation and chemotherapy. Am Surg 2002;236:75-81.
34. Roh M, Petrelli N, Wieand H. Phase III randomised trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03). J Clin Oncol 2001;20(suppl 1):123a.
35. Rouanet P, Rivoire M, Lelong B et al. Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma. A French multicenter prospective trial: GERRCAR 1. J Clin Oncol 2006;24(18 suppl): 152s.
36. Bujko K, Kepka L, Michalski W et al. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006; 80:4-12.
37. Kuvshinoff B, Maghfoor I, Miedema B et al. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: Are ≤ 1 cm distal margins sufficient? Ann Surg Oncol 2001;8:163-169.
38. Chmielik E, Bujko K, Nasierowska-Guttmejer A et al. Distal intramural spread of rectal cancer after preoperative radiotherapy: The results of a multicenter randomized clinical study. Int J Radiat Oncol Biol Phys 2006;65: 182-188.
39. Rengan R, Paty PB, Wong WD et al. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: Increased local failure rate in nonresponders. Clin Colorectal Cancer 2006;5:413-421.
40. Hyams DM, Mamounas EP, Petrelli N et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum 1997;40:131-139.
41. Roh MS, Colangelo L, Wieand S et al. Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. J Clin Oncol 2004;22(suppl 14S):246s.
42. Sauer R, Fietkau R, Wittekind C et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: The German trial CAO/ARO/AIO-94. Strahlenther Onkol 2001;177:173-181.
43. Gerard JP, Chapet O, Nemoz C et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial. J Clin Oncol 2004;22:2404-2409.
44. Boulis-Wassif S, Gerard A, Loygue J et al. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984;53:1811-1818.
45. Bosset JF, Calais G, Daban A. Does the addition of chemotherapy to radiation increase acute toxicity in patients with rectal cancer: Report of 22921 EORTC phase III trial. J Clin Oncol 2003;21:294.
46. Chau I, Brown G, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006;24:668-674.
47. Browman GP, Levine MN, Hodson DI et al. The Head and Neck Radiotherapy Questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993;11:863-872.
48. Bosset JF, Magnin V, Maingon P et al. Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000;46:323-327.
49. Janjan NA, Crane C, Feig BW et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-112.
50. Bruce J, Krukowski ZH, Al-Khairy G et al. Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 2001;88:1157-1168.
51. Sauer R, Fietkau R, Wittekind C et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: The German trial CAO/ ARO/AIO-94. Colorectal Dis 2003;5:406-415.
52. Hartley A, Ho KF, McConkey C et al. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: Analysis of phase II/III trials. Br J Radiol 2005;78:934-938.